BioCentury
ARTICLE | Clinical News

MethylPatch: Phase III

April 8, 2002 7:00 AM UTC

In a placebo-controlled Phase III trial in about 200 children aged 6-12 with ADHD, MethylPatch significantly improved the primary endpoint of teacher ratings using the IOWA scale (p<0.001). In NOVN's ...